First half revenues and operating profits dropped 5% and 7% respectively at Invibio Biomaterials Solutions, indicating toughening business and pricing conditions for PEEK medical plastics used in implants. “We have seen revenue growth in Asia of 6% and in our developing markets of 5%. However, this was more than offset by the impact of continued de-stocking at selected spine customers,” Victrex Chairman Anita Frew said. Tagging Options Domain:  All Sites Keywords:  PEEK Invibio implants Solvay read more

Read More:
Competition heats up in PEEK implants